COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,889 Articles (22,568 medRxiv, 8,321 bioRxiv)

Most recent first Previous |  Page 2983: Articles 29821-29830  | Next

The Institutional and Cultural Context of Cross-National Variation in COVID-19 Outbreaks
Messner, W.
10.1101/2020.03.30.20047589 — Posted: 2020-04-01 Discussion: Onsite
How will this continue? Modelling interactions between the COVID-19 pandemic and policy responses
Rossberg, A. G., Knell, R. J.
10.1101/2020.03.30.20047597 — Posted: 2020-04-01
Assessing the interactions between COVID-19 and influenza in the United States
Zipfel, C. M., Bansal, S.
10.1101/2020.03.30.20047993 — Posted: 2020-04-01
Transmission Dynamics and Control Methodology of COVID-19: a Modeling Study
Zhu, H.
10.1101/2020.03.29.20047118 — Posted: 2020-04-01
Transmission Dynamics of COVID-19 and Impact on Public Health Policy
Shayak, B., Sharma, M. M., Rand, R. H., Singh, A. K., Misra, A.
10.1101/2020.03.29.20047035 — Posted: 2020-04-01
Perception of emergent epidemic of COVID-2019 / SARS CoV-2 on the Polish Internet
Jarynowski, A., Wojta-Kempa, M., Belik, V.
10.1101/2020.03.29.20046789 — Posted: 2020-04-01
Analytical sensitivity and efficiency comparisons of SARS-COV-2 qRT-PCR assays
Vogels, C. B. F., Brito, A. F., Wyllie, A. L., Fauver, J. R., Ott, I. M., Kalinich, C. C., Petrone, M. E., Landry, M.-L., Foxman, E. F., Grubaugh, N. D.
10.1101/2020.03.30.20048108 — Posted: 2020-04-01 Discussion: Onsite
COVID-19 Epidemic in Switzerland: Growth Prediction and Containment Strategy Using Artificial Intelligence and Big Data
Abhari, R. S., Marini, M., Chokani, N.
10.1101/2020.03.30.20047472 — Posted: 2020-04-01
Optimal timing for social distancing during an epidemic
Patterson-Lomba, O.
10.1101/2020.03.30.20048132 — Posted: 2020-04-01
Early behavior of Madrid Covid-19 disease outbreak: A mathematical model
Garcia-Iglesias, D., de Cos Juez, F. J.
10.1101/2020.03.30.20047019 — Posted: 2020-04-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).